Istanbul Autoshow 2015 is held at TUYAP Fair, Convention and Congress Center on May 22-31 and automobile enthusiasts will meet the “new wonders of the world”
Istanbul Autoshow 2015, organized jointly by ODD (Automotive Distributors' Association) and TUYAP Tüm Fuarcılık Yapım A.Ş., was held at TUYAP Fair, Convention and Congress Center at Beylikdüzü between 22 and 31 May 2015, and more than 60 new models were introduced to car enthusiasts for the first time in Turkey. Among these new models, two of them celebrated their world premiers at the Istanbul Autoshow. TUYAP hosted the Autoshow in its 14 halls on a total indoor area of 120,000 square meters, presenting automotive enthusiasts the new wonders of the world: the latest car models.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7533851-new-wonders-exhibit-Istanbul-autoshow/
Bloomberg Government's "The Digital Trust: Securing Commerce," a five-city tour underwritten by Visa Inc., culminates in Washington, DC on March 26. Business leaders and government officials join Bloomberg Government to discuss ideas and principles learned in this cross-country conversation--redefining the bonds of trust and cooperation between retailers, regulators, Congress and consumers in a new era of digital commerce.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7371431-bloomberg-visa-the-digital-trust-securingcommerce/
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
The American Transaction Processors Coalition (ATPC) formally launched today with a panel discussion in front of 400 industry employees, chamber of commerce executives, university leadership and elected officials from Congress, the Georgia General Assembly and local governments across metro Atlanta.
More than 40,000 employees work directly for 70-plus Georgia-based transaction processing companies within an area known as Transaction Alley. These companies generated more than $30 billion last year, far exceeding other well-known Georgia industries like life sciences at $17 billion or film at $3 billion. Transaction Alley revenues equal that of the entire U.S. movie industry, and is dominated by Atlanta, just as Los Angeles dominates films.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7081851-american-transaction-processors-coalition-launches-georgia-town-hall
At the Mobile World Congress (MWC) exhibition starting today in Barcelona, B.I.S. Advanced Software Systems Ltd. will demonstrate our vast cloud storage capabilities to telecom industry ISPs/MSPs and large enterprises. With B.I.S.’s unique and innovative unified data access and mobility applications, you can generate customer stickiness, increased loyalty, and future profits and better ROI.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65012-BIS-mobile-world-congress-2014-cloud-storage
In a ground-breaking technology move for the automotive industry, Volvo Cars demonstrates the world’s first delivery of food to the car – a new form of ‘roam delivery’ services. The service, which will be showcased at the Mobile World Congress, will allow consumers to have their shopping delivered straight to their car, no matter where they are.
Volvo’s new digital keys technology will allow consumers to choose their car as a delivery option when ordering goods online.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65010-volvo-pilots-roam-delivery-service
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness Day on October 13, MedImmune Specialty Care Division of AstraZeneca (NYSE: AZN) is launching the My+Story online resource center, which highlights the needs of women living with metastatic breast cancer and calls attention to metastatic disease as a key component of October’s National Breast Cancer Awareness Month. Metastatic Breast Cancer Awareness Day was officially recognized by the U.S. Congress in 2009, following a grassroots awareness effort led by members of the Metastatic Breast Cancer Network (MBCN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63080-astrazeneca-metastatic-breast-cancer-awareness
The rising star and one of most well-attended global digital, tech and telco events is about to break the traditional dominance of the Mobile World Congress and CES with amazing keynotes, 200+ first-world-class speakers and 8000+ visitors from 100+ countries
The biggest global ad spenders, digital, tech and telco experts from all over the world gather at the 5th edition of Webit Congress on 6-7 November in Istanbul. Procter and Gamble, Unilever, Acer, Master Card, Nokia and more to join the world's most innovative digital, tech companies, publishers and agencies at Webit Congress 2013
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62393-webit-congress-2013-istanbul
